Fleming Protocol develops a decentralized, open-source platform for drug discovery that connects scientists, investors, and institutions. This ecosystem addresses the inefficiencies in traditional drug development by facilitating collaboration and data sharing, ultimately accelerating the research process.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional drug discovery is often hampered by siloed data, lack of collaboration, and inefficient funding mechanisms, leading to slow progress and high costs. The process lacks transparency and open access to research data, hindering innovation and delaying the development of new treatments.
Solution
Fleming Protocol is building a decentralized, open-source platform designed to connect scientists, investors, and institutions to streamline drug discovery. The platform facilitates secure data sharing and collaborative research, enabling scientists to access a broader range of resources and expertise. By leveraging blockchain technology, Fleming Protocol aims to create a transparent and efficient ecosystem that accelerates the identification and development of novel therapeutics. The platform also provides a mechanism for incentivizing participation and rewarding contributions to the drug discovery process.
Target Audience
The primary target audience includes pharmaceutical companies, research institutions, academic scientists, and investors involved in drug discovery and development.
Features
- Decentralized data storage for secure and transparent data sharing
- Collaborative research tools to facilitate communication and knowledge exchange among scientists
- Blockchain-based incentives to reward contributions to the platform
- Open-source platform for community-driven development and innovation